,
The pharmaceutical industry is undergoing a paradigm shift as health authorities worldwide embrace structured, digital-first labeling formats such as Structured Product Labeling (SPL) and eLabeling. This transformation is redefining Regulatory submissions, enabling better data standardization, interoperability, and patient communication. This white paper explores how SPL and eLabeling are shaping global Regulatory frameworks, the challenges faced by pharmaceutical organizations, and how digital labeling ecosystems can streamline compliance, reduce errors, and accelerate product approvals.
Fill the form below to download the White Paper
